ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
4,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
5,1,Retinal vascular occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
6,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
6,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
6,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
8,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
9,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
10,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
11,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
11,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
11,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
12,2,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
13,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
13,2,Hyperuricaemia,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
13,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
14,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
15,1,Deafness,Hearing losses,Hearing disorders,Ear,N
16,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
18,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
19,1,Deafness,Hearing losses,Hearing disorders,Ear,N
20,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
20,2,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
20,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
21,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
21,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
21,3,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
22,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
23,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,1,Deafness,Hearing losses,Hearing disorders,Ear,N
25,1,Deafness,Hearing losses,Hearing disorders,Ear,N
26,1,Deafness,Hearing losses,Hearing disorders,Ear,N
27,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
28,1,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
29,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
29,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
29,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
30,1,Deafness,Hearing losses,Hearing disorders,Ear,N
30,2,Infusion site infection,Vascular infections,Infections - pathogen unspecified,Infec,N
31,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
31,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
31,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
31,6,Headache,Headaches NEC,Headaches,Nerv,N
31,7,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
31,8,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
31,9,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
31,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
31,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
31,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,14,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
31,15,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,16,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
31,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
33,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
33,2,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
33,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
33,5,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
33,6,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
33,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
33,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
34,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
34,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
34,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
35,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
35,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
36,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
37,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
38,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
38,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
39,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
40,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
40,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
40,3,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
41,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
41,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
41,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
41,5,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
41,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
42,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
43,1,Deafness,Hearing losses,Hearing disorders,Ear,N
43,2,Excessive cerumen production,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
43,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
44,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
44,2,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
44,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
44,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
45,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
46,1,Deafness,Hearing losses,Hearing disorders,Ear,N
47,1,Retinal cyst,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
47,2,Retinal infarction,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
47,3,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
47,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
48,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
50,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
51,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
51,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
52,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
52,2,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
52,3,Pyroglutamate increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
53,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,1,Deafness,Hearing losses,Hearing disorders,Ear,N
54,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
54,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
55,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
55,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
55,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
55,4,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
55,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
56,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
57,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
58,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
58,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
59,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
59,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
59,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
59,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
60,1,Abdominal adhesions,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
60,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,3,Gallstone ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
60,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
61,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
61,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
61,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
61,4,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
62,1,Acoustic neuroma,Neuromas,Nervous system neoplasms benign,Neopl,N
62,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
62,3,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
62,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
62,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
62,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
62,7,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
62,8,Neurilemmoma benign,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
62,9,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
63,1,Acoustic neuroma,Neuromas,Nervous system neoplasms benign,Neopl,N
63,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
63,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
63,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
63,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
63,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
64,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
64,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
64,3,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
64,4,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
65,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
66,1,Acoustic neuroma,Neuromas,Nervous system neoplasms benign,Neopl,N
66,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
66,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,4,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
67,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
68,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
70,1,Deafness,Hearing losses,Hearing disorders,Ear,N
71,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
71,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
71,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
71,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
71,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
72,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
72,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
73,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
73,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
73,3,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
73,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
73,5,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,Y
73,6,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
73,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
73,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
73,9,Right atrial hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
73,10,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
73,11,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
74,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
74,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
74,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
75,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
75,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
75,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
76,1,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
77,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
77,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
77,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
77,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
77,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
78,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
78,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
79,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
81,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
81,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
81,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
81,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
82,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
82,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
83,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
84,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
85,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
85,2,Deafness,Hearing losses,Hearing disorders,Ear,N
85,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
85,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
86,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
86,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,Y
86,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
86,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
87,1,Deafness,Hearing losses,Hearing disorders,Ear,N
87,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
88,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
88,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
88,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
89,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
89,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
90,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
90,2,Deafness,Hearing losses,Hearing disorders,Ear,N
90,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
90,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
92,2,Deafness,Hearing losses,Hearing disorders,Ear,N
92,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
92,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
93,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
94,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
94,2,Deafness,Hearing losses,Hearing disorders,Ear,N
94,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
94,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
95,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
96,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
96,2,Deafness,Hearing losses,Hearing disorders,Ear,N
96,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
96,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
98,1,Deafness,Hearing losses,Hearing disorders,Ear,N
98,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
99,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
100,2,Deafness,Hearing losses,Hearing disorders,Ear,N
100,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
100,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
101,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,Y
101,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
102,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
102,2,Deafness,Hearing losses,Hearing disorders,Ear,N
102,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
102,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
103,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
103,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
103,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
104,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
105,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
105,2,Deafness,Hearing losses,Hearing disorders,Ear,N
105,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
106,2,Deafness,Hearing losses,Hearing disorders,Ear,N
106,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
106,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
107,1,Deafness,Hearing losses,Hearing disorders,Ear,N
107,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
108,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
108,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
108,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
109,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,Y
109,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
109,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
109,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
110,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
110,2,Deafness,Hearing losses,Hearing disorders,Ear,N
110,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
110,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
111,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
111,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
112,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
112,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
112,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
112,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
113,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
113,2,Deafness,Hearing losses,Hearing disorders,Ear,N
113,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
113,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
113,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
113,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
114,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
114,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
114,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
114,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
115,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
115,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
115,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
115,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
116,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
116,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
117,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
117,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
118,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
119,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
120,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
120,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
120,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
120,4,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
120,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
120,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
120,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
121,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
122,1,Deafness,Hearing losses,Hearing disorders,Ear,N
123,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
123,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
124,1,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
124,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
125,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
126,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
126,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
126,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
126,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
126,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
126,6,Serratia infection,Serratia infections,Bacterial infectious disorders,Infec,N
127,1,Bronchopulmonary dysplasia,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
127,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
127,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
127,4,Necrotising colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
127,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
127,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
128,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
128,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
129,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
129,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
131,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
132,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
133,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
134,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
134,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
134,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
135,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,2,Mixed deafness,Hearing losses,Hearing disorders,Ear,N
136,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
136,2,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
136,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
136,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
136,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
136,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
136,7,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
136,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
136,9,Raoultella ornithinolytica infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
136,10,Serratia sepsis,Serratia infections,Bacterial infectious disorders,Infec,N
136,11,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
137,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
138,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
139,1,Bronchopulmonary dysplasia,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
139,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
139,3,Necrotising enterocolitis neonatal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
139,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
139,5,Sepsis neonatal,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
140,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
140,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
140,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
141,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
141,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
142,1,Aspergillus test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
142,2,Blood creatinine abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
142,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
142,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
142,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
142,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
142,7,Procalcitonin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
142,8,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
143,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
143,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
143,3,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
143,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
143,5,Thalamic infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
144,1,Deafness,Hearing losses,Hearing disorders,Ear,N
145,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,Y
146,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
147,1,Atypical mycobacterium test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
148,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
148,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
149,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
149,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
150,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
150,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
150,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
150,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
150,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
150,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
151,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
151,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
151,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
151,4,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
152,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
153,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
154,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
155,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
155,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
155,3,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
155,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
155,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,6,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,7,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
155,8,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
155,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
155,10,Thalamic infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
155,11,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
155,12,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
155,13,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
156,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
156,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
157,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
158,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
158,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
158,3,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
158,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
158,5,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
158,6,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
158,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
159,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
160,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
160,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
160,3,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
160,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
161,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
162,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
162,2,Middle ear effusion,Middle ear disorders NEC,Middle ear disorders (excl congenital),Ear,N
162,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
162,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
163,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
164,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
164,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
165,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
165,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
165,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
165,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
165,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
166,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
166,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
166,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
167,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
168,1,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
168,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
168,3,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
169,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
169,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
169,3,Purulence,Infections NEC,Infections - pathogen unspecified,Infec,N
170,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
170,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
170,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
170,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
170,5,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
170,6,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
171,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
172,1,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
173,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
173,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
173,3,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
174,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
175,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
175,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
175,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
176,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
176,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
177,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
178,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
179,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
179,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
179,3,Headache,Headaches NEC,Headaches,Nerv,N
179,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
180,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
181,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
181,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
181,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
182,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
182,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
183,1,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
184,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
184,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
184,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
184,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
184,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
185,1,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
186,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
186,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
187,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
187,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
187,3,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
187,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
187,5,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
188,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
188,2,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
188,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
189,1,Device issue,Device issues NEC,Device issues,Prod,N
189,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
189,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
189,4,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
189,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
189,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
190,1,Device delivery system issue,Device issues NEC,Device issues,Prod,N
190,2,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
190,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
191,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
192,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
192,2,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
193,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
193,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
194,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
194,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
195,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
195,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
195,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
196,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
196,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
196,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
197,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
198,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
199,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
199,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
200,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
201,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
202,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
202,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
202,3,Headache,Headaches NEC,Headaches,Nerv,N
202,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
203,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
203,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
203,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
203,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
203,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
204,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
204,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
205,1,Device use error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
205,2,Exposure via mucosa,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
206,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
206,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
206,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
206,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
207,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
207,2,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
207,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
208,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
209,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
209,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
210,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
211,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
212,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
212,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
212,3,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
212,4,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
213,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
214,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
